Biological costs and mechanisms of fosfomycin resistance in Escherichia coli

Antimicrobial Agents and Chemotherapy

Volumn 47, Issue 9, 2003, Pages 2850-2858

  Nilsson, Annika I ^a,b   Berg, Otto G ^c   Aspevall, Olle ^d   Kahlmeter, Gunnar ^e   Andersson, Dan I ^a,b  

^a SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^e CENTRAL HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

FOSFOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL CELL WALL; BACTERIAL GENE; BACTERIAL GROWTH; BACTERIAL MUTATION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; BLADDER; CONTROLLED STUDY; CULTURE MEDIUM; CYAA GENE; DRUG ABSORPTION; DRUG EXCRETION; DRUG MECHANISM; ESCHERICHIA COLI; GLPT GENE; GROWTH RATE; IN VITRO STUDY; IN VIVO STUDY; LABORATORY; MATHEMATICAL MODEL; NONHUMAN; PRIORITY JOURNAL; PTSI GENE; UHPA T GEBE; URINARY TRACT INFECTION;

ANTI-BACTERIAL AGENTS; CARBOHYDRATE METABOLISM; CULTURE MEDIA; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; FEMALE; FOSFOMYCIN; HUMANS; MODELS, BIOLOGICAL; MUTATION; URINARY BLADDER; URINARY TRACT INFECTIONS;

EID: 0042424543     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.47.9.2850-2858.2003     Document Type: Article

References (46)

1. Alper, M. D., and B. N. Ames. 1978. Transport of antibiotics and metabolite analogs by systems under cyclic AMP control: positive selection of Salmonella typhimurium cya and crp mutants. J. Bacteriol. 133:149-157.
2. Andersson, D. I., and B. R. Levin. 1999. The biological cost of antibiotic resistance. Curr. Opin. Microbiol. 2:489-493.
3. Arca, P., C. Hardisson, and J. E. Suarez. 1990. Purification of a glutathione S-transferase that mediates fosfomycin resistance in bacteria. Antimicrob. Agents Chemother. 34:844-848.
4. Arca, P., G. Reguera, and C. Hardisson. 1997. Plasmid-encoded fosfomycin resistance in bacteria isolated from the urinary tract in a multicentre survey. J. Antimicrob. Chemother. 40:393-399.
5. Arca, P., M. Rico, A. F. Brana, C. J. Villar, C. Hardisson, and J. E. Suarez. 1988. Formation of an adduct between fosfomycin and glutathione: a new mechanism of antibiotic resistance in bacteria. Antimicrob. Agents Chemother. 32:1552-1556.
6. Båga, M., M. Göransson, S. Normark, and B. E. Uhlin. 1985. Transcriptional activation of a pap pilus virulence operon from uropathogenic Escherichia coli. EMBO J. 4:3887-3893.
7. Bergan, T. 1995. Pharmacokinetics of fosfomycin. Rev. Contemp. Pharmacother. 6:55-62.
8. Björkholm, B., M. Sjölund, P. G. Falk, O. G. Berg, L. Engstrand, and D. I. Andersson. 2001. Mutation frequency and biological cost of antibiotic resistance in Helicobacter pylori. Proc. Natl. Acad. Sci. USA 98:14607-14612.
9. Björkman, J., and D. I. Andersson. 2000. The cost of antibiotic resistance from a bacterial perspective. Drug Resist. Update 3:237-245.
10. Björkman, J., D. Hughes, and D. I. Andersson. 1998. Virulence of antibiotic-resistant Salmonella typhimurium. Proc. Natl. Acad. Sci. USA 95:3949-3953.
11. Björkman, J., I. Nagaev, O. G. Berg, D. Hughes, and D. I. Andersson. 2000. Effects of environment on compensatory mutations to ameliorate costs of antibiotic resistance. Science 287:1479-1482.
12. Carlone, N. A., M. Borsotto, A. M. Cuffini, and D. Savoia. 1987. Effect of fosfomycin trometamol on bacterial adhesion in comparison with other chemotherapeutic agents. Eur. Urol. 13:86-91.
13. Gismondo, M. R., L Drago, C. Fassina, M. L. Garlaschi, M. Rosina, and A. Lombardi. 1994. Escherichia coli: effect of fosfomycin trometamol on some urovirulence factors. J. Chemother. 6:167-172.
14. Gordon, D. M., and M. A. Riley. 1992. A theoretical and experimental analysis of bacterial growth in the bladder. Mol Microbiol. 6:555-562.
15. Hultgren, S. J., W. R. Schwan, A. J. Schaeffer, and J. L. Duncan. 1986. Regulation of production of type 1 pili among urinary tract isolates of Escherichia coli. Infect. Immun. 54:613-620.
16. Kadner, R. J. 1995. Expression of the Uhp sugar-phosphate transport system of Escherichia coli, p. 263-274. In J. A. Hoch and T. J. Silhavy (ed.), Two-component signal transduction. ASM Press, Washington, D.C.
17. Kadner, R. J., and H. H. Winkler. 1973. Isolation and characterization of mutations affecting the transport of hexose phosphates in Escherichia coli. J. Bacteriol. 113:895-900.
18. Kahan, F. M., J. S. Kahan, P. J. Cassidy, and H. Kropp. 1974. The mechanism of action of fosfomycin (phosphonomycin). Ann. N.Y. Acad. Sci. 235:364-386.
19. Kahlmeter, G. 2000. The ECO.SENS Project: a prospective, multinational, multicentre epidemiological survey of the prevalence and antimicrobial susceptibility of urinary tract pathogens - interim report. J. Antimicrob. Chemother. 46(Suppl. 1):15-22; discussion, 63-65.
20. Kahlmeter, G., D. F. J. Brown, F. W. Goldestein, A. P. MacGowan, J. W. Mouton, A. österlund, A. Rodloff, M. Steinbakk, P. Urbaskova, and A. Vatopoulos. European harmonization of MCI breakpoints for antimicrobial susceptibility testing of bacteria. J. Antimicrob. Chemother., in press.
21. Klein, U., M. Pawelzik, and W. Opferkuch. 1985. Influence of beta-lactam antibiotics, fosfomycin and vancomycin on the adherence (hemagglutination) of Escherichia coli-containing different adhesins. Chemotherapy 31:138-145.
22. Kronvall, G., G. Kahlmeter, E. Myhre, and M. F. Galas. 2003. A new method for normalized interpretation of antimicrobial resistance from disk test results for comparative purposes. Clin. Microbiol. Infect. 9:120-132.
23. Langermann, S., S. Palaszynski, M. Barnhart, G. Auguste, J. S. Pinkner, J. Burlein, P. Barren, S. Koenig, S. Leath, C. H. Jones, and S. J. Hultgren. 1997. Prevention of mucosal Escherichia coli infection by FimH-adhesin-based systemic vaccination. Science 276:607-611.
24. Lea, D. E., and C. A. Coulson. 1949. The distribution of the number of mutants in bacterial populations. J. Genet. 49:264-285.
25. Levin, B. R. 2001. Minimizing potential resistance: a population dynamics view. Clin. Infect. Dis. 33(Suppl. 3):S161-S169.
26. Levin, B. R., M. Lipsitch, V. Perrot, S. Schrag, R. Antia, L. Simonsen, N. M. Walker, and F. M. Stewart. 1997. The population genetics of antibiotic resistance. Clin. Infect. Dis. 24(Suppl. 1):S9-S16.
27. Li Pira, G., C. Pruzzo, and G. C. Schito. 1987. Monuril and modification of pathogenicity traits in resistant microorganisms. Eur. Urol. 13:92-97.
28. Luria, S. E., and M. Delbrück. 1943. Mutations of bacteria from virus sensitivity to virus resistance. Genetics 28:491-511.
29. Maisnier-Patin, S., O. G. Berg, L. Liljas, and D. I. Andersson. 2002. Compensatory adaptation to the deleterious effect of antibiotic resistance in Salmonella typhimurium. Mol. Microbiol. 46:355-366.
30. Merkel, T. J., J. L. Dahl, R. H. Ebright, and R. J. Kadner. 1995. Transcription activation at the Escherichia coli uhpT promoter by the catabolite gene activator protein. J. Bacteriol. 177:1712-1718.
31. Minassian, M. A., and J. D. Williams. 1995. The clinical pharmacology of fosfomycin trometamol. Rev. Contemp. Pharmacother. 6:45-53.
32. Mulvey, M. A., J. D. Schilling, J. J. Martinez, and S. J. Hultgren. 2000. Bad bugs and beleaguered bladders: interplay between uropathogenic Escherichia coli and innate host defenses. Proc. Natl. Acad. Sci. USA 97:8829-8835.
33. Nagaev, I., J. Björkman, D. I. Andersson, and D. Hughes. 2001. Biological cost and compensatory evolution in fusidic acid-resistant Staphylococcus aureus. Mol. Microbiol. 40:433-439.
34. Neuman, M., and F. Rufin. 1987. Activity of Monuril in lower urinary tract infections due to fosfomycin-resistant bacteria. Eur. Urol. 13:105-107.
35. Olekhnovich, I. N., J. L. Dahl, and R. J. Kadner. 1999. Separate contributions of UhpA and CAP to activation of transcription of the uhpT promoter of Escherichia coli. J. Mol. Biol. 292:973-986.
36. Österberg, E., H. O. Hallander, A. Kallner, A. Lundin, S. B. Svensson, and H. Åberg. 1990. Female urinary tract infection in primary health care: bacteriological and clinical characteristics. Scand. J. Infect. Dis. 22:477-484.
37. Reynolds, M. G. 2000. Compensatory evolution in rifampin-resistant Escherichia coli. Genetics 156:1471-1481.
38. Roberts, F. J. 1986. Quantitative urine culture in patients with urinary tract infection and bacteremia. Am. J. Clin. Pathol. 85:616-618.
39. Schaaper, R. M., and R. L. Dunn. 1991. Spontaneous mutation in the Escherichia etichia coli lacI gene. Genetics 129:317-326.
40. Schrag, S. J., and V. Perrot. 1996. Reducing antibiotic resistance. Nature 381:120-121.
41. Schrag, S. J., V. Perrot, and B. R. Levin. 1997. Adaptation to the fitness costs of antibiotic resistance in Escherichia coli. Proc. R. Soc. Lond. B Biol. Sci. 264:1287-1291.
42. Schumacher, G., and K. Bussmann. 1978. Cell-free synthesis of proteins related to sn-glycerol-3-phosphate transport in Escherichia coli. J. Bacteriol. 135:239-250.
43. Sherman, D. R., K. Mdluli, M. J. Hickey, T. M. Arain, S. L. Morris, C. E. Barry 3rd, and C. K. Stover. 1996. Compensatory ahpC gene expression in isoniazid-resistant Mycobacterium tuberculosis. Science 272:1641-1643.
44. Stamm, W. E., K. F. Wagner, R. Amsel, E. R. Alexander, M. Turck, G. W. Counts, and K. K. Holmes. 1980. Causes of the acute urethral syndrome in women. N. Engl. J. Med. 303:409-415.
45. Tsuruoka, T., A. Miyata, and Y. Yamada. 1978. Two kinds of mutants defective in multiple carbohydrate utilization isolated from in vitro fosfomycin-resistant strains of Escherichia coli K-12. J. Antibiot. (Tokyo) 31:192-201.
46. Yamamura, E., T. Nunoshiba, M. Kawata, and K. Yamamoto. 2000. Characterization of spontaneous mutation in the oxyR strain of Escherichia coli. Biochem. Biophys. Res. Commun. 279:427-432.